Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial update of tadalafil (LY450190) in Chinese men with erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2017-10-27